Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1200

Actual shortage: 256 (21%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (0%)
Resolved: 943 (79%)

Discontinuation Reports

222

To be discontinued: 3 (1%)
Discontinued: 219 (99%)
Reversed: 0 (0%)

Late reports

226 (16%)

Overdue reports

5 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
TEVA-ANASTROZOLE 1MG TABLET Actual shortage 2020-01-24 2020-10-15 104374
ACT BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
ACT BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-03 2020-05-08 110797
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-23 2020-05-08 113043
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-08 113726
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2020-06-25 2020-09-24 118960
ACT CABERGOLINE 0.5MG TABLET Actual shortage 2017-05-03 2017-10-05 8767
ACT CELECOXIB 100MG CAPSULE Resolved 2017-03-17 2018-10-11 3390

Showing 1 to 20 of 1200

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-06-11 2020-06-11 117546
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-09-24 2020-09-24 124899
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION To be discontinued 2019-07-05 2019-07-05 88619
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-09-27 2019-10-01 94980

Showing 201 to 220 of 222